Mark Valadao

Mark Valadao is a seasoned professional in venture capital and private equity with a focus on technology, health tech, and life sciences. They served as Managing Director at Skymont Capital, investing in exclusive real estate opportunities across Asia. Currently, Valadao advises multiple companies, including DRL Diagnostic Research Laboratory and Emma Health, both of which are innovating in precision oncology and chronic disease management, respectively. Their extensive experience also includes senior roles at Mellon Capital and State Street Global Advisors, where they managed significant assets and developed strategic investment solutions. Valadao's expertise is complemented by advisory roles in emerging biotech companies, further underscoring their impact in the healthcare sector.